Consumer Defensive
Sunset Capital Assets, Inc.(SNST)
Live Price
Offline$0.001
+0.00% today
1Y Change
+900.00%
Window
Jun 20, 2025 → Jun 18, 2026
- Market Cap
- —
- Revenue Growth
- -96.9%
- EPS Growth
- +82.4%
- Dividend Yield
- 0.0%
Coverage: 255 bars · Jun 20, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sunset Capital Assets, Inc. (SNST) is a Consumer Defensive stock with listed on OTC. The stock last traded around $0.00 and up 900.0% across the available one-year price window (Jun 20, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -96.9%, EPS growth of +82.4%, a dividend yield of 0.0%. What stands out right now is revenue -96.9%, EPS +82.4%, free cash flow +98.8% with operating margin -2013.5% and ROIC -46.6%. Valuation already assumes a fairly strong business story at price/sales 8.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SNST price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-96.9% vs +1.7% peer median
Operating Margin
Below sector median
-2013.5% vs +6.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -96.9% and EPS is at +82.4%, with operating margin around -2013.5%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNST
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SNST Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SNST and SPY.
Company Overview
Sunset Capital Assets, Inc.
Other OTC
Aphex BioCleanse Systems, Inc. develops sanitizing solutions without the use of alcohol. It products includes sanitizers, surface disinfectants, wound wash, and solutions for treatment of livestock. The company was incorporated in 2010 and is based in Rochester, New York.
- Leadership
- Scott Buckley
- IPO Date
- Feb 9, 2012
- Street Address
- 15 Fishers Road
- Mailing
- Rochester, NY, 14534
- Region
- Rochester, NY, US
- Reporting Currency
- USD
- Investor Line
- 585 798 7775
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 8.6
- Price/Book
- —
Growth
- Revenue
- -96.9%
- EPS
- +82.4%
- Free Cash Flow
- +98.8%
Profitability
- Gross Margin
- -380.2%
- Operating Margin
- -2013.5%
- Net Margin
- -2036.3%
- ROE
- -159.0%
- ROIC
- -46.6%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 3.22
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.